By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


GlobeImmune, Inc. 

1450 Infinite Drive

Louisville  Colorado  80027  U.S.A.
Phone: 303-625-2700 Fax: 303-625-2710


Company News
GlobeImmune (GBIM) Announces Majority Stock Sale 3/24/2017 9:55:15 AM
Reeling From GlobeImmune (GBIM) Hepatitis B Termination, Gilead (GILD) Faces Merck & Co. (MRK), GlaxoSmithKline (GSK) Competition 11/22/2016 6:09:37 AM
Embattled GlobeImmune (GBIM) Loses Gilead (GILD) Deal, Cancels HQ Lease, and CEO Resigns 11/17/2016 4:35:19 PM
GlobeImmune (GBIM) Announces Delisting And Deregistration Of Common Stock 7/6/2016 8:29:02 AM
Stock Pop Gives Hints that GlobeImmune (GBIM) Might Be Fielding Takeover Offers 6/20/2016 7:36:12 AM
GlobeImmune (GBIM) Considers Sales or Closure After Bleak Q1 Financials 5/12/2016 9:52:52 AM
GlobeImmune (GBIM) Announces Updates And Financial Results For Full Year 2015 3/16/2016 9:18:07 AM
GlobeImmune (GBIM) Announces Third Quarter 2015 Results And Corporate Highlight 11/13/2015 10:54:26 AM
GlobeImmune (GBIM) Announces Second Quarter 2015 Results And Corporate Highlights 8/14/2015 9:31:16 AM
Struggling GlobeImmune (GBIM) Taps Financial Adviser to Assist in "Strategic Alternatives" 8/13/2015 7:23:16 AM